{
    "nctId": "NCT05333328",
    "briefTitle": "OFS in Premenopausal Node+ Breast Cancer With Low Genomic Risk",
    "officialTitle": "Endocrine Therapies With Ovarian Function Suppression in Premenopausal Node+ Early Breast Cancer With Low Genomic Risk (INTERSTELLAR Trial, KBCSG-25)",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer, Estrogen Receptor Positive Tumor, HER2-negative Breast Cancer, Premenopausal Breast Cancer, Node-positive Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE4",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 418,
    "primaryOutcomeMeasure": "Distant recurrence-free survival",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* ER+HER2- breast cancer\n* Premenopausal and age \\<=50\n* T1 or T2\n* N1 including micrometastasis\n* Genomic Low Risk by OncoFREE test\u00ae (1-20)\n\nExclusion Criteria:\n\n* Postmenopausal women\n* ER-negative breast cancer",
    "sex": "FEMALE",
    "minimumAge": "20 Years",
    "stdAges": "ADULT"
}